Why the study?
Are factor V Leiden and G20210A prothrombin mutations associated with residual vein obstruction after anticoagulation for idiopathic deep-vein thrombosis?
Are factor V Leiden and G20210A prothrombin mutations associated with residual vein obstruction after anticoagulation for idiopathic deep-vein thrombosis?
Factor V Leiden and G20210A prothrombin mutations do not predict residual vein obstruction after standard anticoagulation for idiopathic DVT, though male sex and isolated DVT are significant predictors.
Answers are grounded in this paper and cite their sources.
Factor V Leiden and prothrombin mutations should not guide residual vein obstruction assessment after idiopathic DVT; leaves open male sex and isolated DVT as predictors for prospective validation.
It was our aim to assess whether factor V Leiden (FVL) and G20210A prothrombin (FII) mutation are associated with the presence of residual vein obstruction (RVO) after a standard course of anticoagulation for a first episode of idiopathic proximal deep-vein thrombosis (DVT) of the lower limbs, with or without symptomatic pulmonary embolism (PE). Patients were enrolled in two prospective multicentre studies: PROLONG and PROLONG II. RVO was detected by compression ultrasonography according to the method of Prandoni on the day of anticoagulation withdrawal. Patients were also screened for FVL and FII mutation. The presence of FVL and/or FII mutation was determined in 872/963 (90.5%) patients, in 753 of whom RVO was assessed. FVL was significantly less frequent among subjects with isolated PE (7/176:4%) than among patients with either DVT and PE (15/133:11.3%; p=0.0018) or isolated DVT (89/563:15.8%; p<0.0001), confirming the FVL paradox. The rate of FII mutation was similar among patients with isolated PE (11/176:6.2%) and patients with either DVT and PE (12/133:9%) or isolated DVT (52/563:9.2%). FVL and FII mutation were not significantly associated with RVO at the multivariate analysis in all patients, although data suggest that FVL and FII mutation may have a differential effect on RVO in the subgroups of patients with DVT and DVT plus PE patients. Male sex and isolated DVT were significantly associated with RVO in all patients. In conclusion, male sex and isolated DVT are associated with RVO, while FVL and FII mutations are not significantly associated with RVO in this study.
No takes yet. Share an insight, caveat, or question.
Legnani et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: